After a surprise construction, Xinghuo Biotech finally built a factory.

On December 2, Zhou Yu came to the factory not far from the company's headquarters to inspect.

Wang Jian led Zhou Yu to visit the factory and introduced the latest situation of the product.

Director Wang Xiaoxiao led the scientific research workers of the Institute of Life Sciences to cooperate with major medical institutions in Yanjing to conduct clinical trials of three products.

After the broadcast of the documentary-style advertisement, many critically ill patients applied for clinical trials.

Their addition has improved the data of many diseases, so that the progress of clinical trials is very fast, and the competent authorities have also sent experts to keep an eye on the data of clinical trials.

Because of the great pressure in society, many well-known people and veteran cadres wrote letters to the competent authorities, asking them to quickly review products such as cell missiles.

After the competent authority determines the safety and true effect of our products, the drugs that have been reviewed and approved by us have been issued, and they can be officially marketed. ”

"Things are going very well, let's take a look at the situation in the factory first, the production of drugs is normal and the storage is enough, and we start to go to market.

I have instructed Xinghuo Intelligence Company that they have trained the Artificial Intelligence Holy Hand, and there will be an Artificial Intelligence Holy Hand to guide the doctor in using medicine. Zhou Yu said happily.

He knew that after these three drugs were launched, they would definitely be targeted by domestic and foreign pharmaceutical groups, but these three drugs were all drugs that benefited the country and the people.

According to expert estimates, they could increase the average life expectancy in China by at least 5 years and reduce the premature mortality rate of children under the age of 10 by 95%.

At the same time, it also surpassed artificial intelligence and software games to become the most profitable project of Xinghuo Technology.

For the sake of profit and reputation, they are now not afraid of any challenge.

As long as you don't have the ability to wipe Spark Technology off the earth, business wars and other battles, the size of Spark Technology is simply not to be feared.

Wang Jian took Zhou Yu into the factory, which was full of huge glass jars.

The glass jar is tightly sealed, the product is completely kept sterile, the hologram is displayed on the glass jar, and there are numerous sensors to monitor every data of the product.

Zhou Yu had long learned about the production process of the pharmacy from Director Wang Xiaoxiao.

In addition to the disease screening agent, the other two agents were inspired by the study of hematopoietic stem cells.

The production of these three drugs is also inseparable from cell culture technology, which is actually a veritable cell factory.

Zhou Yu and Wang Jian walked to the production workshop, which was made up of thousands of small jars, which were the production equipment for disease screening drugs.

Zhou Yu immediately remembered the process of producing disease screening drugs.

Disease screening agents are a group of complex peptide solutions, and more than 1,000 kinds of peptides are mixed together to form disease screening agents.

Each peptide can and can only react with one pheromone in human plasma, and the result of the reaction is that the polypeptide chain folds to form a fluorescent protein.

Just test the type of fluorescent protein in the reagent. The disease of the sample provider can be read.

Each polypeptide is expressed by a small piece of gene fragment constructed by modern gene technology, and the gene fragment is transplanted into a yeast cell screened by the laboratory.

During the proliferation of yeast cells, a large number of polypeptide substances are produced.

All the peptides are mixed together to become disease screening agents.

Wang Jian introduced to Zhou Yu: "The disease screening agent is a polypeptide solvent, which is best stored at about zero degrees, and once the temperature breaks through 40 degrees, the polypeptide chain will automatically dehydrate and condense, losing the effect of detecting diseases.

Each disease screening agent is made into a reagent bottle the size of a little finger and transported to a medical institution by a special vehicle.

The instrument for the use of disease screening agents has been handed over to Xinghuo Precision Manufacturing Company for production, and they have a lot of orders. ”

Zhou Yu and Wang Jian walked to the production workshop on the left, where there were many glass jars filled with red liquid and light yellow liquid, which looked like the production equipment for blood cells and plasma.

The technology of plasma production is very simple, water accounts for about 92%, most of which are plasma proteins, containing a small amount of nutrients, electrolytes, enzymes, hormones, etc.

As long as the optimal ratio is mastered, it is easy to synthesize plasma.

The real difficulty is the production of blood cells, especially platelets and red blood cells, which are functional cells that play a decisive role in the blood, and which must be made viable by industrial cells.

Director Wang Xiaoxiao has cultivated hematopoietic stem cells similar to cancer cells through genetic modification technology.

These genetically modified hematopoietic stem cells are completely different from cancer cells.

Cancer cells have the ability to multiply indefinitely, but they have lost their ability to differentiate.

Genetically modified hematopoietic stem cells have the ability to proliferate indefinitely as cancer cells, but they still maintain the ability to differentiate functional cells.

When hematopoietic stem cells are cultured in nutrients, they have the ability to proliferate indefinitely and can reproduce themselves quickly.

Once induced by chemical agents, these hematopoietic stem cells differentiate into corresponding blood cells, mainly red blood cells, white blood cells, and platelets.

Wang Jian pointed to these canisters and said: "This is the artificial blood produced by our company, which can now produce 10 tons of artificial blood per day.

We encapsulate various types of blood, and our company has its own transport fleet to transport finished blood by professional vehicles.

We also cooperate with the railway company to transport blood through the high-speed rail backbone network by attaching special high-speed rail carriages. ”

When Zhou Yu heard Wang Jian's introduction, he was a little surprised, the method of cooperation with the railway company was completely negotiated by Wang Jian on his own ability.

This method is really good, the fastest is by air, but the transportation of artificial blood is very demanding, and the aircraft needs to be modified, so the transportation cost is too high.

The rest is through high-speed rail transportation, the cost of transforming a carriage, Xinghuo Biotechnology can afford, but the most important problem is to open up the channel of the railway company.

"You have done a great job in this matter, if it is really emergency blood, you can send people to carry it by air on a small scale, and the way of factory transportation, the high-speed railway network is really a good choice." Zhou Yu praised.

They finally came to the cell missile production workshop, which was also a tall giant tank.

Cell-missile production is similar to hematopoietic stem cells, which first stimulate lymphoblast B cells with antigens to produce plasma cells that can produce specific antibodies.

Then, through gene modification technology, plasma cells have the ability to proliferate indefinitely, and at the same time, the ability to produce antibodies is changed by modifying genes.

In this way, the genetically modified plasma cells are placed in the culture medium, and it can produce the same antibody over and over again.

Wang Jian introduced: "The cell missile is a mature protein antibody, which is very well adapted to ultra-low temperature, and can also withstand high temperatures of about 50 degrees.

It only needs to change the material of the packaging, and it can be transported by room temperature. ”

Zhou Yu looked at the huge cell factory that had no one and was running autonomously.

He said with emotion: "It is this not too big cell factory that will rewrite the trajectory of human medical development."